Unilever/€UNA
1D1W1MYTD1Y5YMAX
Capital at risk
About Unilever
- Ticker
- €UNA
- Sector
- Consumer Essentials
- Primary listing
- AEX
- Employees
- 93,732
- Headquarters
- London, United Kingdom
- Website
- www.unilever.com
Unilever Metrics
BasicAdvanced
€114B
12.53
€4.23
0.45
€1.85
3.50%
Price and volume
Market cap
€114B
Beta
0.45
52-week high
€63.39
52-week low
€46.97
Average daily volume
984K
Dividend rate
€1.85
Financial strength
Current ratio
0.74
Quick ratio
0.568
Long term debt to equity
1.309
Total debt to equity
1.754
Dividend payout ratio (TTM)
45.85%
Interest coverage (TTM)
8.79%
Profitability
EBITDA (TTM)
10,876
Gross margin (TTM)
47.07%
Net profit margin (TTM)
18.32%
Operating margin (TTM)
20.03%
Effective tax rate (TTM)
30.59%
Revenue per employee (TTM)
€540,000
Management effectiveness
Return on assets (TTM)
8.29%
Return on equity (TTM)
31.87%
Valuation
Price to earnings (TTM)
12.526
Price to revenue (TTM)
2.279
Price to book
5.98
Price to tangible book (TTM)
-4.87
Price to free cash flow (TTM)
16.446
Free cash flow yield (TTM)
6.08%
Free cash flow per share (TTM)
3.221
Dividend yield (TTM)
3.50%
Growth
Revenue change (TTM)
8.01%
Earnings per share change (TTM)
76.96%
3-year revenue growth (CAGR)
-5.97%
10-year revenue growth (CAGR)
-0.38%
3-year earnings per share growth (CAGR)
0.80%
10-year earnings per share growth (CAGR)
6.81%
3-year dividend per share growth (CAGR)
-0.47%
10-year dividend per share growth (CAGR)
4.23%
Bulls say / Bears say
Unilever delivered 4.8% underlying sales growth in the first half of 2026, including 4.2% volume growth, while second-quarter volume rose 5.5%. Management upgraded full-year guidance to 4%–6% sales growth with about 3% volume growth, suggesting the recovery is becoming more durable. (Unilever, Reuters)
The planned Foods combination with McCormick would leave Unilever focused on Beauty, Wellbeing, Personal Care and Home Care, which have a stronger recent growth profile. The deal also supports shareholder returns, with Unilever targeting €6 billion of buy-backs between 2026 and 2029. (Unilever, Reuters)
The core brands are gaining traction: Beauty & Wellbeing grew 5.9% in the first half, led by double-digit growth from Dove, Sunsilk and Vaseline, while Personal Care rose 4.8%. This shows that premium innovation and stronger marketing are translating into demand rather than relying only on price increases. (Unilever, Unilever)
The second half depends more heavily on price increases to offset roughly €550 million of expected inflation, and Unilever expects some volume sensitivity as prices rise. Gross margin already fell 70 basis points to 46.8% in the first half, so the recovery could prove less profitable than the headline volume growth suggests. (Unilever, Unilever)
Selling Foods removes a historically high-margin business and leaves management needing to prove that faster-growing personal and home-care categories can replace its earnings contribution. Foods volumes also fell 0.1% in the second quarter, highlighting both the strategic rationale and the execution risk around the separation. (Reuters, Reuters)
Currency remains a sizeable earnings risk: a 4.9% foreign-exchange drag largely offset first-half operational gains, leaving reported turnover up only 0.5%. Underlying EPS rose 2.4%, but reported diluted EPS fell 2.5%, showing how a good operating performance can still produce weak euro-denominated results. (Unilever, Unilever)
Data summarised monthly by Lightyear AI. Last updated on 17 Sept 2026.
Unilever Financial Performance
Revenues and expenses
Unilever Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Unilever
AllEURGBP
Fund name | Fund size | €UNA weighting |
|---|---|---|
VanEck Morningstar Developed Markets Dividend Leaders€TDIV | €754M | 2.16% |
VanEck Morningstar Developed Markets Dividend Leaders£TDGB | £655M | 2.16% |
Amundi STOXX Europe 600 ESG€C6E | €735M | 1.19% |
Amundi Index MSCI Europe£CE2D | £5.1B | 1.02% |
Xtrackers MSCI Europe£XMEU | £6.7B | 0.96% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.